Enliven Therapeutics To Present Updated Phase 1 ELVN-001 Data In Chronic Myeloid Leukemia At EHA 2026 And Host Investor Webcast On June 11 At 8:30 a.m. ET

뉴스 본문을 불러오고 있어요.

Enliven Therapeutics To Present Updated Phase 1 ELVN-001 Data In Chronic Myeloid Leukemia At EHA 2026 And Host Investor Webcast On June 11 At 8:30 a.m. ET | 웨이프 WAPE

Enliven Therapeutics To Present Updated Phase 1 ELVN-001 Data In Chronic Myeloid Leukemia At EHA 2026 And Host Investor Webcast On June 11 At 8:30 a.m. ET

기사 요약

관련 종목

댓글 —